Elevated matrix metalloproteinase-2 and-3 production from human diabetic dermal fibroblasts

被引:71
作者
Wall, SJ
Sampson, MJ [1 ]
Levell, N
Murphy, G
机构
[1] Norfolk & Norwich Univ Hosp, Bertram Diabet Res Unit, Norwich NR4 7UY, Norfolk, England
[2] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
[3] Norfolk & Norwich Univ Hosp, Dermatol Ctr, Norwich NR4 7UY, Norfolk, England
关键词
diabetes mellitus; fibroblasts; matrix metalloproteinase; wound healing;
D O I
10.1046/j.1365-2133.2003.05262.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Diabetic foot ulcers are characterized by elevated levels of matrix metalloproteinases (MMP), which could lead to excessive matrix breakdown and disruption to healing. It is unknown if this elevation is a function of wound healing, or if it is present within normal skin and a primary contributor to the increased risk of impaired healing. Objectives To determine whether diabetic fibroblasts from unwounded skin show elevated MMP production compared with their nondiabetic counterparts. Patients and methods Circular skin biopsies (4 mm diameter) were taken from the inside upper arm of four controls without diabetes and from four subjects with insulin-treated diabetes. Fibroblasts were incubated for a further 72 h and conditioned medium was collected and stored at -20 degreesC. The conditioned medium was assessed by gelatin zymography and Western blotting for MMP-2 and MMP-3. Results Diabetic dermal fibroblasts showed significantly elevated production of MMP-2 (P < 0.05) and pro-MMP-3 (P < 0.05) when compared with their nondiabetic counterparts. Conclusions Dermal fibroblasts from normal unwounded skin are characterized by increased MMP production and this may be a primary contributing factor to the increased risk of nonhealing foot ulceration in diabetes.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 18 条
[1]   Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells [J].
Anderson, SS ;
Wu, KJ ;
Nagase, H ;
StettlerStevenson, WG ;
Kim, YK ;
Tsilibary, EC .
CELL ADHESION AND COMMUNICATION, 1996, 4 (02) :89-101
[2]   ENHANCEMENT OF WOUND-HEALING BY TOPICAL TREATMENT WITH EPIDERMAL GROWTH-FACTOR [J].
BROWN, GL ;
NANNEY, LB ;
GRIFFEN, J ;
CRAMER, AB ;
YANCEY, JM ;
CURTSINGER, LJ ;
HOLTZIN, L ;
SCHULTZ, GS ;
JURKIEWICZ, MJ ;
LYNCH, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (02) :76-79
[3]  
Clark RAF., 1998, MOL CELLULAR BIOL F, P3, DOI [10.1007/978-1-4615-1795-5_1, DOI 10.1007/978-1-4615-1795-5_1]
[4]   DETERMINATION OF ENDOGENOUS CYTOKINES IN CHRONIC WOUNDS [J].
COOPER, DM ;
YU, EZ ;
HENNESSEY, P ;
KO, F ;
ROBSON, MC .
ANNALS OF SURGERY, 1994, 219 (06) :688-692
[5]   Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment [J].
Desfaits, AC ;
Serri, O ;
Renier, G .
DIABETES CARE, 1998, 21 (04) :487-493
[6]   DIABETES IMPAIRS THE LATE INFLAMMATORY RESPONSE TO WOUND-HEALING [J].
FAHEY, TJ ;
SADATY, A ;
JONES, WG ;
BARBER, A ;
SMOLLER, B ;
SHIRES, GT .
JOURNAL OF SURGICAL RESEARCH, 1991, 50 (04) :308-313
[7]   ELECTROPHORETIC ANALYSIS OF PLASMINOGEN ACTIVATORS IN POLYACRYLAMIDE GELS CONTAINING SODIUM DODECYL-SULFATE AND COPOLYMERIZED SUBSTRATES [J].
HEUSSEN, C ;
DOWDLE, EB .
ANALYTICAL BIOCHEMISTRY, 1980, 102 (01) :196-202
[8]  
KJELLSTROM T, 1986, DIABETES RES CLIN EX, V3, P77
[9]  
Lobmann R, 2000, DIABETOLOGIA, V43, pA15
[10]   Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds [J].
Loots, MAM ;
Lamme, EN ;
Zeegelaar, J ;
Mekkes, JR ;
Bos, JD ;
Middelkoop, E .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (05) :850-857